Robust earnings seen for UMediC


Affin Hwang said there is superior earnings potential for UMedic in the near term, coupled with its scarcity as the only listed Malaysian player in this field.

PETALING JAYA: Distributor of medical equipment and consumables, UMediC Group Bhd, is in a good position to chalk up strong earnings in the near term amid downside risks.

The company is not only the sole listed Malaysian entity in this field, but has the manufacturing capacity to add on new products to meet global demand.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
UMedic , production , expansion , demand , earnings , margins

Next In Business News

Property segment set for solid expansion
BLand in proposed name change
Vestland terminates three jobs worth RM551mil
Uneven gains forecast from global chip upcycle
Strong year on the cards for consumer sector
Affin Bank set to shine on structural changes, digital platforms
BMW launches first locally assembled EV
Positive view on TM’s plan to lower staffing costs
REITs expected to outperform this year
SCIB shareholders approve rights issue at EGM

Others Also Read